{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:44:14Z","timestamp":1779900254470,"version":"3.53.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.critrevonc.2013.10.008","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T22:30:15Z","timestamp":1383949815000},"page":"1-15","source":"Crossref","is-referenced-by-count":67,"title":["Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis\u2014A critical review"],"prefix":"10.1016","volume":"89","author":[{"given":"Yves","family":"Beguin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Aapro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Mizzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00d6sterborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1349-7006.2008.01001.x","article-title":"Role of iron in carcinogenesis: cancer as a ferrotoxic disease","volume":"100","author":"Toyokuni","year":"2009","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of Mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"issue":"5\u20136","key":"10.1016\/j.critrevonc.2013.10.008_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/10408360701428257","article-title":"The regulation of cellular iron metabolism","volume":"44","author":"Chua","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2008.02.038","article-title":"Redox signaling and cancer: the role of labile iron","volume":"266","author":"Galaris","year":"2008","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"issue":"2\u20133","key":"10.1016\/j.critrevonc.2013.10.008_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-5793(00)01920-7","article-title":"LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity","volume":"480","author":"Krause","year":"2000","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0035","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3945\/jn.108.102905","article-title":"Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells","volume":"139","author":"Chung","year":"2009","journal-title":"J Nutr"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0040","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro","year":"2001","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0045","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","article-title":"Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial","volume":"22","author":"Auerbach","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0050","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.10763","article-title":"Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy","volume":"95","author":"Crawford","year":"2002","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0055","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mds112","article-title":"Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron","volume":"23","author":"Aapro","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.10.008_bib0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ajh.21779","article-title":"Darbepoetin alfa 300 or 500\u03bcg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia","volume":"85","author":"Auerbach","year":"2010","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0065","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2006.10.4620","article-title":"Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia","volume":"26","author":"Bastit","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.leu.2404562","article-title":"Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study","volume":"21","author":"Hedenus","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1634\/theoncologist.12-2-231","article-title":"Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy","volume":"12","author":"Henry","year":"2007","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0080","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2007.12.2051","article-title":"Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha","volume":"26","author":"Pedrazzoli","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1615\/CritRevOncog.2013007889","article-title":"Iron, erythropoietic stimulating agents, and anemia in cancer","volume":"18","author":"Adamson","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0090","series-title":"NCCN practice guidelines in oncology; cancer and chemotherapy-induced anemia \u2013 v.2","author":"National Comprehensive Cancer Network Inc.","year":"2014"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.10.008_bib0095","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2010-08-300541","article-title":"American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer","volume":"116","author":"Rizzo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0100","first-page":"7","article-title":"What is the right balance between iron and erythropoiesis stimulating agents in chemotherapy induced anemia","volume":"1","author":"Auerbach","year":"2009","journal-title":"Eur J Clin Med Oncol"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V112.11.54.54","article-title":"Darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation: a prospective randomized multicenter trial","volume":"112","author":"Beguin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02489833","article-title":"Iron and carcinogenesis in laboratory animals and humans: a mechanistic consideration and a review of literature","volume":"3","author":"Okada","year":"1998","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0115","first-page":"19","article-title":"The role of iron in cancer","volume":"5","author":"Weinberg","year":"1996","journal-title":"Eur J Cancer Prev"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0120","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0125","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/hep.21885","article-title":"Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls","volume":"46","author":"Ellervik","year":"2007","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1016\/j.critrevonc.2013.10.008_bib0140","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2006.12.002","article-title":"Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study","volume":"38","author":"Rivers","year":"2007","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2007.03.008","article-title":"SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent","volume":"39","author":"Barton","year":"2007","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0155","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s10620-008-0287-x","article-title":"Hemochromatosis gene status as a risk factor for Barrett's esophagus","volume":"53","author":"Corley","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.2910600204","article-title":"Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark","volume":"60","author":"Hsing","year":"1995","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/1055-9965.EPI-03-0188","article-title":"Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer","volume":"13","author":"Kallianpur","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q","article-title":"Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis","volume":"76","author":"Nelson","year":"1995","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2013.10.008_bib0175","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/jnci\/95.2.154","article-title":"Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer","volume":"95","author":"Shaheen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-4-1","article-title":"Iron: a target for the management of Kaposi's sarcoma?","volume":"4","author":"Simonart","year":"2004","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0190","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3748\/wjg.v16.i6.663","article-title":"Iron: an emerging factor in colorectal carcinogenesis","volume":"16","author":"Chua","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0195","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/01635580902803701","article-title":"A possible link between iron deficiency and gastrointestinal carcinogenesis","volume":"61","author":"Pra","year":"2009","journal-title":"Nutr Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.293.2.172","article-title":"Meat consumption and risk of colorectal cancer","volume":"293","author":"Chao","year":"2005","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1753-4887.2001.tb07002.x","article-title":"Iron and colorectal cancer risk: human studies","volume":"59","author":"Nelson","year":"2001","journal-title":"Nutr Rev"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0210","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/dji164","article-title":"Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition","volume":"97","author":"Norat","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.bjc.6603837","article-title":"A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women","volume":"97","author":"Kabat","year":"2007","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<693::AID-IJC11>3.0.CO;2-G","article-title":"Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study","volume":"80","author":"Kato","year":"1999","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0225","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI64373","article-title":"Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans","volume":"123","author":"Noto","year":"2013","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0230","first-page":"2358","article-title":"Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat","volume":"63","author":"Cross","year":"2003","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0235","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/1055-9965.EPI-07-0086","article-title":"Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study","volume":"16","author":"Kabat","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0240","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/ijc.24404","article-title":"Dietary and stored iron as predictors of breast cancer risk: A nested case-control study in Shanghai","volume":"125","author":"Moore","year":"2009","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10549-007-9538-3","article-title":"Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study","volume":"107","author":"Kallianpur","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0250","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/sj.bjc.6604110","article-title":"Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study","volume":"98","author":"Kabat","year":"2008","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0255","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/aje\/152.12.1145","article-title":"Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men","volume":"152","author":"Michaud","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0260","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/aje\/kwi131","article-title":"Iron, lipids, and risk of cancer in the Framingham Offspring cohort","volume":"161","author":"Mainous","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0265","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1370\/afm.283","article-title":"Transferrin saturation, dietary iron intake, and risk of cancer","volume":"3","author":"Mainous","year":"2005","journal-title":"Ann Fam Med"},{"issue":"16","key":"10.1016\/j.critrevonc.2013.10.008_bib0270","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198810203191603","article-title":"Body iron stores and the risk of cancer","volume":"319","author":"Stevens","year":"1988","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0275","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijc.2910560312","article-title":"Moderate elevation of body iron level and increased risk of cancer occurrence and death","volume":"56","author":"Stevens","year":"1994","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0280","first-page":"505","article-title":"Iron, cholesterol, and the risk of cancer in an 18-year cohort","volume":"6","author":"Wells","year":"2005","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1047-2797(03)00119-4","article-title":"Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults","volume":"14","author":"Wu","year":"2004","journal-title":"Ann Epidemiol"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0290","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10552-013-0219-8","article-title":"Iron metabolism and risk of cancer in the Swedish AMORIS study","volume":"24","author":"Gaur","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.10.008_bib0295","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/jn\/135.11.2664","article-title":"Iron status and risk of cancers in the SU.VI.MAX cohort","volume":"135","author":"Hercberg","year":"2005","journal-title":"J Nutr"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0300","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jnci\/djn084","article-title":"Donation frequency, iron loss, and risk of cancer among blood donors","volume":"100","author":"Edgren","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.critrevonc.2013.10.008_bib0305","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djn209","article-title":"Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial","volume":"100","author":"Zacharski","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0310","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s00535-007-2095-z","article-title":"Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C","volume":"42","author":"Kato","year":"2007","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0315","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1289\/ehp.931009","article-title":"Mechanisms of multistep carcinogenesis and carcinogen risk assessment","volume":"100","author":"Barrett","year":"1993","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0320","first-page":"109","article-title":"On the carcinogenicity of an iron-dextran complex","volume":"24","author":"HADDOW","year":"1960","journal-title":"J Natl Cancer Inst"},{"issue":"5127","key":"10.1016\/j.critrevonc.2013.10.008_bib0325","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/bmj.1.5127.947","article-title":"Induction of sarcoma in the rat by iron\u2013dextran complex","volume":"1","author":"Richmond","year":"1959","journal-title":"Br Med J"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0330","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/path.1700820223","article-title":"Tissue changes following injection of iron\u2013dextran complex","volume":"82","author":"Baker","year":"1961","journal-title":"J Path Bact"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.1968.16","article-title":"The effects of iron\u2013dextran on squirrel monkeys (Saimiri sciurea)","volume":"22","author":"Carter","year":"1968","journal-title":"Br J Cancer"},{"issue":"5398","key":"10.1016\/j.critrevonc.2013.10.008_bib0340","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1136\/bmj.1.5398.1588","article-title":"Induction of Sarcomata in rabbits by intramuscular injection of iron\u2013dextran (IMFERON)","volume":"1","author":"Haddow","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0345","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/bjc.1964.93","article-title":"Iron\u2013dextran carcinogenesis in rats: effect of distributing injected material between one, two, four, or six sites","volume":"18","author":"Roe","year":"1964","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2010.30.3644","article-title":"Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia","volume":"29","author":"Steensma","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0355","first-page":"107","article-title":"Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats","volume":"76","author":"Ebina","year":"1986","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0360","first-page":"1867","article-title":"Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate","volume":"47","author":"Li","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0365","series-title":"Iron therapy with special emphasis on intravenous administration","author":"Crichton","year":"2008"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0370","first-page":"199","article-title":"Effects of phlebotomy on the growth of ferric nitrilotriacetate-induced renal cell carcinoma","volume":"56","author":"Mizote","year":"2002","journal-title":"Acta Med Okayama"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0375","first-page":"869","article-title":"Renal tumors in rats given trisodium nitrilotriacetic acid in drinking water for 2 years","volume":"66","author":"Goyer","year":"1981","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.10.008_bib0380","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1349-7006.2006.00301.x","article-title":"Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment","volume":"97","author":"Jiang","year":"2006","journal-title":"Cancer Sci"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0385","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/carcin\/6.6.907","article-title":"Dose-related effect of trisodium nitrilotriacetate monohydrate on renal tumorigenesis initiated with N-ethyl-N-hydroxyethylnitrosamine in rats","volume":"6","author":"Hiasa","year":"1985","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0390","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijc.2910430325","article-title":"Carcinogenicity of iron in conjunction with a chlorinated environmental chemical, hexachlorobenzene, in C57BL\/10ScSn mice","volume":"43","author":"Smith","year":"1989","journal-title":"Int J Cancer"},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2013.10.008_bib0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/bj2910029","article-title":"Genetic variation of iron-induced uroporphyria in mice","volume":"291","author":"Smith","year":"1993","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0400","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/carcin\/11.3.437","article-title":"Iron as a synergist for hepatocellular carcinoma induced by polychlorinated biphenyls in Ah-responsive C57BL\/10ScSn mice","volume":"11","author":"Smith","year":"1990","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0405","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/carcin\/18.3.599","article-title":"Iron promotes DEN initiated GST-P foci in rat liver","volume":"18","author":"Carthew","year":"1997","journal-title":"Carcinogenesis"},{"issue":"5\u20136","key":"10.1016\/j.critrevonc.2013.10.008_bib0410","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/13510002.1997.11747127","article-title":"Evidence that iron-overload promotes 7,12-dimethylbenz(a)anthracene- induced skin tumorigenesis in mice","volume":"3","author":"Rezazadeh","year":"1997","journal-title":"Redox Rep"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0415","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00512-0","article-title":"Effect of iron overload on the benzoyl peroxide-mediated tumor promotion in mouse skin","volume":"126","author":"Rezazadeh","year":"1998","journal-title":"Cancer Lett"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.10.008_bib0420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/096032701682693044","article-title":"Role of iron\u2013dextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice","volume":"20","author":"Rezazadeh","year":"2001","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00204-003-0525-0","article-title":"Free radical generating agents lead to the rapid progression of benign skin tumors to carcinoma in iron-overloaded mice","volume":"78","author":"Bhasin","year":"2004","journal-title":"Arch Toxicol"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0430","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0278-6915(02)00056-X","article-title":"Low iron state is associated with reduced tumor promotion in a two-stage mouse skin carcinogenesis model","volume":"40","author":"Bhasin","year":"2002","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0435","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1191\/0960327105ht544oa","article-title":"Evidence that iron overload plus croton oil induce skin tumours in mice","volume":"24","author":"Rezazadeh","year":"2005","journal-title":"Hum Exp Toxicol"},{"issue":"9","key":"10.1016\/j.critrevonc.2013.10.008_bib0440","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/carcin\/20.9.1801","article-title":"An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload","volume":"20","author":"Chen","year":"1999","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0445","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1023\/A:1015362228659","article-title":"Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice","volume":"47","author":"Seril","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0450","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10620-005-2560-6","article-title":"Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet","volume":"50","author":"Seril","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0455","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1207\/s15327914nc4902_7","article-title":"Dietary iron promotes azoxymethane-induced colon tumors in mice","volume":"49","author":"Ilsley","year":"2004","journal-title":"Nutr Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0460","first-page":"1477","article-title":"The effect of iron on experimental colorectal carcinogenesis","volume":"9","author":"Nelson","year":"1989","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0465","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/01635589409514354","article-title":"Effect of iron deficiency on DMH-induced gastrointestinal tract tumors and occurrence of hepatocyte abnormalities in Fischer rats","volume":"22","author":"Jagadeesan","year":"1994","journal-title":"Nutr Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.10.008_bib0470","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/1097-0142(19911201)68:11<2407::AID-CNCR2820681113>3.0.CO;2-N","article-title":"Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice","volume":"68","author":"Hann","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0475","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jn\/122.1.46","article-title":"Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats","volume":"122","author":"Spear","year":"1992","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0480","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/carcin\/12.1.111","article-title":"Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea","volume":"12","author":"Thompson","year":"1991","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0485","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/carcin\/19.7.1285","article-title":"Enhancement of estrogen-induced renal tumorigenesis in hamsters by dietary iron","volume":"19","author":"Wyllie","year":"1998","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0490","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2174\/0929867013372931","article-title":"Role of iron in estrogen-induced cancer","volume":"8","author":"Liehr","year":"2001","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0495","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1677\/jme.0.0290305","article-title":"Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells","volume":"29","author":"Vyhlidal","year":"2002","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0500","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/bjc.1983.62","article-title":"The effect of iron deficiency on experimental oral carcinogenesis in the rat","volume":"47","author":"Prime","year":"1983","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0505","first-page":"209","article-title":"Influence of low dietary iron and iron overload on urethan-induced lung tumors in mice","volume":"57","author":"Omara","year":"1993","journal-title":"Can J Vet Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0510","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jn\/115.3.369","article-title":"Influence of iron on in vivo proliferation and lethality of L1210 cells","volume":"115","author":"Bergeron","year":"1985","journal-title":"J Nutr"},{"issue":"10","key":"10.1016\/j.critrevonc.2013.10.008_bib0515","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gut.2006.094060","article-title":"Modulation of iron transport proteins in human colorectal carcinogenesis","volume":"55","author":"Brookes","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0520","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1078-0432.CCR-07-1054","article-title":"Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma","volume":"14","author":"Boult","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.critrevonc.2013.10.008_bib0525","first-page":"4168","article-title":"Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice","volume":"48","author":"Hann","year":"1988","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0530","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbagen.2008.04.003","article-title":"Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents","volume":"1790","author":"Richardson","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0535","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1615\/CritRevOncog.2013007921","article-title":"Iron chelation: inhibition of key signaling pathways in the induction of the epithelial mesenchymal transition in pancreatic cancer and other tumors","volume":"18","author":"Richardson","year":"2013","journal-title":"Crit Rev Oncog"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0540","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol Rev"},{"issue":"16","key":"10.1016\/j.critrevonc.2013.10.008_bib0545","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.4161\/cc.6.16.4603","article-title":"Tuning cell cycle regulation with an iron key","volume":"6","author":"Yu","year":"2007","journal-title":"Cell Cycle"},{"issue":"15","key":"10.1016\/j.critrevonc.2013.10.008_bib0550","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2174\/1568026043387269","article-title":"Iron chelators in cancer chemotherapy","volume":"4","author":"Buss","year":"2004","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0555","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/1097-0142(19921015)70:8<2051::AID-CNCR2820700806>3.0.CO;2-1","article-title":"Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice","volume":"70","author":"Hann","year":"1992","journal-title":"Cancer"},{"issue":"1A","key":"10.1016\/j.critrevonc.2013.10.008_bib0560","first-page":"445","article-title":"Inhibitory effect of deferoxamine mesylate and low iron diet on the 13762NF rat mammary adenocarcinoma","volume":"19","author":"Wang","year":"1999","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0565","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1023\/A:1026661508553","article-title":"Iron chelator deferoxamine reduces preneoplastic lesions in liver induced by choline-deficient l-amino acid-defined diet in rats","volume":"44","author":"Sakaida","year":"1999","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0570","first-page":"473","article-title":"Failure of iron chelators to reduce tumor growth in human neuroblastoma xenografts","volume":"58","author":"Selig","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-8258(03)00226-9","article-title":"Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice","volume":"90","author":"Simonart","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0580","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ijc.10475","article-title":"Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model","volume":"100","author":"Simonart","year":"2002","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0585","first-page":"2685","article-title":"Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo","volume":"22","author":"Jiang","year":"2002","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0590","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"issue":"40","key":"10.1016\/j.critrevonc.2013.10.008_bib0595","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0600","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0705089","article-title":"Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agents","volume":"138","author":"Becker","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"21","key":"10.1016\/j.critrevonc.2013.10.008_bib0605","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1158\/1078-0432.CCR-04-0865","article-title":"Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation","volume":"10","author":"Chaston","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0610","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2011-12-399667","article-title":"Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation","volume":"120","author":"Roth","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0615","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12185-008-0120-5","article-title":"Body iron metabolism and pathophysiology of iron overload","volume":"88","author":"Kohgo","year":"2008","journal-title":"Int J Hematol"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2013.10.008_bib0620","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrfmmm.2003.08.004","article-title":"Labile iron pool: the main determinant of cellular response to oxidative stress","volume":"531","author":"Kruszewski","year":"2003","journal-title":"Mutat Res"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2013.10.008_bib0625","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mrfmmm.2007.01.012","article-title":"Blood mononucleocytes are sensitive to the DNA damaging effects of iron overload \u2013 in vitro and ex vivo results with human and rat cells","volume":"619","author":"Park","year":"2007","journal-title":"Mutat Res"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0630","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tiv.2005.11.009","article-title":"Ferric iron increases ROS formation, modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cells","volume":"20","author":"Knobel","year":"2006","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0635","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.fct.2006.10.028","article-title":"Ferric iron is genotoxic in non-transformed and preneoplastic human colon cells","volume":"45","author":"Knobel","year":"2007","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0640","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tiv.2009.01.004","article-title":"Influence of inorganic and organic iron compounds on parameters of cell growth and survival in human colon cells","volume":"23","author":"Klenow","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0645","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-8-2","article-title":"Neoplastic transformation of rat liver epithelial cells is enhanced by non-transferrin-bound iron","volume":"8","author":"Messner","year":"2008","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0650","first-page":"759","article-title":"Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas","volume":"30","author":"Jiang","year":"2010","journal-title":"Anticancer Res"},{"issue":"43","key":"10.1016\/j.critrevonc.2013.10.008_bib0655","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and iron regulation in breast cancer progression and prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci Transl Med"},{"issue":"49","key":"10.1016\/j.critrevonc.2013.10.008_bib0660","doi-asserted-by":"crossref","first-page":"33911","DOI":"10.1074\/jbc.M806432200","article-title":"Post-transcriptional modulation of iron homeostasis during p53-dependent growth arrest","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0665","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagen.2008.08.006","article-title":"Iron metabolism in the anemia of chronic disease","volume":"1790","author":"Weiss","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0670","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2007.06638.x","article-title":"Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53","volume":"138","author":"Weizer-Stern","year":"2007","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0675","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.onc.1210711","article-title":"A role for iron in Wnt signalling","volume":"27","author":"Brookes","year":"2008","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0680","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.celrep.2012.07.003","article-title":"Luminal iron levels govern intestinal tumorigenesis after Apc loss in vivo","volume":"2","author":"Radulescu","year":"2012","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0685","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/jcp.20229","article-title":"Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression","volume":"203","author":"Habel","year":"2005","journal-title":"J Cell Physiol"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0690","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/10715760500484344","article-title":"Free radicals act as effectors in the growth inhibition and apoptosis of iron-treated Burkitt's lymphoma cells","volume":"40","author":"Habel","year":"2006","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0695","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coi.2009.01.011","article-title":"Iron in innate immunity: starve the invaders","volume":"21","author":"Ganz","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"35","key":"10.1016\/j.critrevonc.2013.10.008_bib0700","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.3748\/wjg.v13.i35.4707","article-title":"Iron overload and immunity","volume":"13","author":"Porto","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.critrevonc.2013.10.008_bib0705","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s12098-010-0120-3","article-title":"Iron deficiency and infection","volume":"77","author":"Kumar","year":"2010","journal-title":"Indian J Pediatr"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0710","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/ajcn\/79.3.516","article-title":"Immune function is impaired in iron-deficient, homebound, older women","volume":"79","author":"Ahluwalia","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.critrevonc.2013.10.008_bib0715","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1182\/blood-2004-07-2686","article-title":"Iron regulates T-lymphocyte sensitivity to the IFN-gamma\/STAT1 signaling pathway in vitro and in vivo","volume":"105","author":"Regis","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2013.10.008_bib0720","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2362.2002.0320s1070.x","article-title":"immunity: a double-edged sword","volume":"32","author":"Weiss","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0725","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1189\/jlb.0802420","article-title":"Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells","volume":"74","author":"Oexle","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.critrevonc.2013.10.008_bib0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.clml.2013.06.001","article-title":"Prevalence of iron overload vs iron deficiency in multiple myeloma: resembling or different from MDS-and stem cell transplant (SCT)-patients?","author":"Konig","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"14","key":"10.1016\/j.critrevonc.2013.10.008_bib0735","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/jnci\/djn225","article-title":"Cancer as a ferrotoxic disease: are we getting hard stainless evidence?","volume":"100","author":"Edgren","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0740","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2141.2003.03590.x","article-title":"Pharmacokinetics and red cell utilization of 52Fe\/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography","volume":"120","author":"Beshara","year":"2003","journal-title":"Br J Haematol"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2013.10.008_bib0745","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 2","key":"10.1016\/j.critrevonc.2013.10.008_bib0750","first-page":"S107","article-title":"Labile iron: manifestations and clinical implications","volume":"15","author":"Van Wyck","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.critrevonc.2013.10.008_bib0755","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1093\/ndt\/gfq260","article-title":"Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds","volume":"25","author":"Toblli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"6a","key":"10.1016\/j.critrevonc.2013.10.008_bib0760","first-page":"345","article-title":"The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose","volume":"60","author":"Funk","year":"2010","journal-title":"Arzneimittelforschung"},{"issue":"12","key":"10.1016\/j.critrevonc.2013.10.008_bib0765","first-page":"1439","article-title":"Structure\/histotoxicity relationship of parenteral iron preparations","volume":"42","author":"Geisser","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0770","first-page":"11","article-title":"The pharmacology and safety profile of ferric carboxymaltose (Ferinject\u00ae): structure\/reactivity relationships of iron preparations","volume":"23","author":"Geisser","year":"2009","journal-title":"Port J Nephrol Hypert"},{"issue":"1","key":"10.1016\/j.critrevonc.2013.10.008_bib0775","first-page":"53","article-title":"Differences between the original iron sucrose complex Venofer\u00ae and the iron sucrose similar Generis\u00ae, and potential implications","volume":"23","author":"Toblli","year":"2009","journal-title":"Port J Nephrol Hypert"},{"issue":"6","key":"10.1016\/j.critrevonc.2013.10.008_bib0780","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.25122","article-title":"Pattern of declining hemoglobin concentration before cancer diagnosis","volume":"127","author":"Edgren","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2013.10.008_bib0785","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/bjc.1989.344","article-title":"Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats","volume":"60","author":"Okada","year":"1989","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2013.10.008_bib0790","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/labinvest.2009.140","article-title":"Homozygous deletion of CDKN2A\/2B is a hallmark of iron-induced high-grade rat mesothelioma","volume":"90","author":"Hu","year":"2010","journal-title":"Lab Invest"},{"issue":"4","key":"10.1016\/j.critrevonc.2013.10.008_bib0795","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI118875","article-title":"Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats","volume":"98","author":"Kato","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.critrevonc.2013.10.008_bib0800","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0003-9861(02)00616-1","article-title":"Progressive iron overload enhances chemically mediated tumor promotion in murine skin","volume":"409","author":"Bhasin","year":"2003","journal-title":"Arch Biochem Biophys"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842813002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T16:33:43Z","timestamp":1596818023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842813002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":160,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1040842813002308"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2013.10.008","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}